PMID: 18200897Jan 19, 2008Paper

5 Million Lives Campaign. Reducing methicillin-resistant Staphylococcus aureus (MRSA) infections

Joint Commission Journal on Quality and Patient Safety
Frances A Griffin

Abstract

Hospital-acquired infections from methicillin-resistant Staphylococcus aureus (MRSA) now account for more than 60% of S. aureus infections in intensive care patients reported to the Centers for Disease Control and Prevention (CDC). Media stories have raised the profile of this problem, and several states have moved toward legislative action regarding screening of hospital patients or mandatory reporting of infections. Guidelines from clinical expert organizations, including the CDC, the Association for Professionals in Infection Control and Epidemiology (APIC), and the Society for Healthcare Epidemiology of America (SHEA), recommend the use of basic prevention practices to avoid transmission in the hospital setting, yet concerns persist that compliance with these practices is neither consistent nor reliable. The campaign's MRSA intervention recommends five key components of care. These are not intended to be an all-inclusive list but rather have been recommended by experts as the minimum necessary components: (1) hand hygiene, (2) decontamination of the environment and equipment, (3) active surveillance, (4) contact precautions for infected and colonized patients, and (5) device bundles (central line bundle and ventilator bundl...Continue Reading

References

Aug 1, 1986·Infection Control : IC·L M Kaplan, M McGuckin
Sep 1, 1982·Annals of Internal Medicine·R L ThompsonR P Wenzel
Dec 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M D SanfordR P Wenzel
Jun 11, 1998·Emerging Infectious Diseases·M M HuyckeM S Gilmore
Mar 6, 1999·Annals of Internal Medicine·D PittetT V Perneger
Mar 19, 1999·Emerging Infectious Diseases·R J RubinA Moiduddin
Nov 24, 1999·JAMA : the Journal of the American Medical Association·C ChaixC Brun-Buisson
Mar 10, 2001·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·T KimA E Simor
Feb 27, 2003·Emerging Infectious Diseases·Mary G LankfordLance R Peterson
Jun 6, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Carlene A MutoUNKNOWN SHEA
Jun 21, 2005·Diagnostic Microbiology and Infectious Disease·Thomas P Lodise, Peggy S McKinnon
Feb 16, 2006·Cleveland Clinic Journal of Medicine·Rebecca H Sunenshine, L Clifford McDonald
Mar 15, 2006·Archives of Internal Medicine·Jon P FurunoEli N Perencevich
Mar 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·M C J BootsmaM J M Bonten
Sep 20, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Susan S HuangRichard Platt
Oct 13, 2006·Archives of Internal Medicine·Susan S HuangRichard Platt
Oct 18, 2007·JAMA : the Journal of the American Medical Association·R Monina KlevensUNKNOWN Active Bacterial Core surveillance (ABCs) MRSA Investigators
Dec 11, 2007·American Journal of Infection Control·Jane D SiegelUNKNOWN Healthcare Infection Control Practices Advisory Committee

❮ Previous
Next ❯

Citations

Aug 18, 2010·Health Care Management Science·James C Benneyan, Aysun Taşeli
Jan 29, 2013·The Journal of Trauma and Acute Care Surgery·Mark J SeamonSteven E Ross
May 10, 2011·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Marcia M WardLoreen Herwaldt
Oct 21, 2011·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Sean L BarnesJon P Furuno

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
E Yoko FuruyaMaryam Behta
Archives of Internal Medicine
Jean-Christophe LucetStaphylococcus aureus Resistant a la Meticilline en Hospitalisation A Domicile (SARM HAD) Study Group
© 2021 Meta ULC. All rights reserved